MRI1 Inhibitors
MRI1 Inhibitors are a diverse group of chemical compounds that act upon various kinases and signaling pathways involved in the functional regulation of MRI1. One common target among these inhibitors is the protein kinase C (PKC) pathway. Compounds such as Staurosporine and GF109203X serve as broad and specific PKC inhibitors, respectively. The inhibition of PKC leads to reduced phosphorylation of substrates that interact with MRI1, thereby decreasing its functional activity. The inhibition of PKC, thus, serves as a critical control point, downregulating the functional activity of MRI1 indirectly by reducing the phosphorylation state of proteins that regulate MRI1.
Another significant pathway influencing MRI1 activity is the PI3K/Akt/mTOR signaling axis. Compounds like LY294002 and Wortmannin are PI3K inhibitors, which result in the downregulation of Akt phosphorylation. Akt is a kinase that can phosphorylate various substrates, potentially modulating the interactions and activation of MRI1. Through the inhibition of PI3K and Akt, these compounds decrease the phosphorylation and activity of proteins that are crucial for MRI1 function.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Non-selective protein kinase inhibitor that inhibits a broad range of kinases including PKC, which can phosphorylate substrates involved in the activation of MRI1. Inhibition of PKC can reduce the phosphorylation of these substrates, leading to a decrease in MRI1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that leads to a decrease in Akt phosphorylation. Since Akt can phosphorylate various proteins that may interact with and activate MRI1, inhibition of Akt signaling can result in reduced MRI1 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that disrupts the mTORC1 complex, a key regulator of protein synthesis and cell growth. By inhibiting mTORC1, rapamycin can decrease the synthesis of proteins that are essential for MRI1 function, leading to its functional inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that prevents the activation of the ERK pathway. MRI1 activity can be modulated by ERK-mediated signaling events; thus, blocking this pathway with U0126 can lead to a reduction in MRI1 functional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that impairs the p38 signaling pathway. Given that p38 MAPK can influence several proteins and transcription factors that regulate MRI1 activity, SB203580 can diminish MRI1 functional capacity by inhibiting this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that prevents the phosphorylation of c-Jun and the activation of AP-1 transcription factor. As AP-1 can regulate genes that encode proteins interacting with MRI1, SP600125 can decrease MRI1 activity through inhibition of JNK signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor similar to LY294002, wortmannin can inhibit the PI3K/Akt pathway, resulting in decreased activation of downstream effectors that contribute to MRI1 activity, leading to its functional inhibition. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that blocks the activation of ERK1/2 kinases, which are involved in cell proliferation and survival pathways that can regulate MRI1 activity. PD98059 can therefore decrease the functional activity of MRI1 by inhibiting the ERK pathway. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Akt inhibitor that specifically prevents Akt phosphorylation and activation. By directly inhibiting Akt, triciribine can reduce the activity of downstream proteins that modulate MRI1 function, leading to decreased MRI1 activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Specific PKC inhibitor that can prevent the phosphorylation of PKC substrates, which are potentially involved in the regulation of MRI1 activity. Inhibition of PKC by GF109203X can thus result in reduced functional activity of MRI1. | ||||||